BogenschutzM. P.ForcehimesA. A.PommyJ. A.WilcoxC. E.BarbosaP. C.StrassmanR. J. (2015). Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study. Journal of Psychopharmacology, 29(3), 289–299. https://doi.org/10.1177/0269881114565144
2.
Carhart-HarrisR. L.BolstridgeM.RuckerJ.DayC. M. J.ErritzoeD.KaelenM.BloomfieldM.RickardJ. A.ForbesB.FeildingA.TaylorD.PillingS.CurranV. H.NuttD. J. (2016). Psilocybin with psychological support for treatment-resistant depression: An open- label feasibility study. The Lancet Psychiatry, 3(7), 619–627. https://doi.org/10.1016/S2215-0366(16)30065-7
3.
GriffithsR. R.JohnsonM. W.CarducciM. A.UmbrichtA.RichardsW. A.RichardsB. D.CosimanoM. P.KlinedinstM. A. (2016). Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. Journal of Psychopharmacology, 30, 1181–1197.
4.
GriffithsR. R.RichardsW. A.McCannU.JesseR. (2006). Psilocybin can occasion mystical experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology, 187, 268–283.
5.
GrobC. S.DanforthA. L.ChopraG. S.HagertyM.McKayC. R.HalberstadtA. L.GreerG. (2011). Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Archive of General Psychiatry, 68, 71–78.
6.
JohnsonM. W.Garcia-RomeuA.CosimanoM. P.GriffithsR. R. (2014). Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. Journal of Psychopharmacology, 28(11), 983–992.
7.
PahnkeW. (1963, June). Drugs and mysticism: An analysis of the relationship between psychedelic drugs and the mystical consciousness [Paper presentation]. Harvard University.
8.
RossS.BossisA.GussJ.Agin-LiebesG.MaloneT.CohenB.MennengaS. E.BelserA.KalliontziK.BabbJ.SuZ.CorbyP.SchmidtB. L. (2016). Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: A randomized controlled trial. Journal of Psychopharmacology, 30, 1165–1180.
9.
SiegelJ. S.DailyJ. E.PerryD. A.NicolG. E. (2023). Psychedelic drug legislative reform and legalization in the US. JAMA Psychiatry, 80(1), 77–83. https://doi.org/10.1001/jamapsychiatry.2022.4101